ArticleEuropean heart journal. Case reports2025
Atypical gastrointestinal presentation of hereditary transthyretin amyloidosis: a case report highlighting the diagnostic challenge.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hereditary transthyretin amyloidosis (ATTR) is a rare, progressive multisystem disease, often underdiagnosed due to its heterogeneous presentation. This case highlights an atypical presentation of ATTR amyloidosis dominated by gastrointestinal symptoms and the diagnostic pitfalls associated with certain genetic subtypes that may escape standard imaging modalities. Case summary: We present a 68-year-old man with severe gastrointestinal symptoms and extreme weight loss, over a prolonged period. Initial investigations were inconclusive across multiple centres. A deep intestinal biopsy eventually revealed amyloid deposition, and subsequent genetic testing confirmed hereditary ATTR amyloidosis. Cardiac magnetic resonance imaging revealed myocardial involvement despite a negative 99mTc-HDP scintigraphy. The patient was referred for targeted therapy. Discussion: This case underscores the need for high clinical suspicion and a multidisciplinary approach when encountering unexplained gastrointestinal and cardiac symptoms. It also demonstrates the value of the European Society of Cardiology guidelines as a reliable reference point for guiding further management when diagnostic uncertainty arises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.